Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens (Q35977233)

11 August 2017

Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens (English)

1 reference

11 August 2017

5

Fosså SD

1 reference

11 August 2017

2

Nesland JM

1 reference

11 August 2017

Berner A

1

1 reference

11 August 2017

Waehre H

series ordinal

3

1 reference

11 August 2017

Silde J

series ordinal

4

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 August 1993

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

68

1 reference

11 August 2017

2

1 reference

11 August 2017

380-384

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1993.344

11 August 2017

0 references

cites work

The p53 tumour suppressor gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

Expression of c-erbB-2 protein product in bladder cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

Deoxyribonucleic Acid Ploidy and the Direct Assay of Prostatic Acid Phosphatase and Prostate Specific Antigen in Fine Needle Aspiration Biopsies as Diagnostic Methods in Prostatic Carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

Prognostic value of c-erbB-2 expression in uterine cervical carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

DNA flow cytometry and histopathological grading of paraffin-embedded prostate biopsy specimens in a survival study.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

Stage A versus stage B adenocarcinoma of the prostate: morphological comparison and biological significance.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

Natural history of localised prostatic cancer. A population-based study in 223 untreated patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

Expectant management of localized prostatic cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

Neuro-endocrine cells--a new prognostic parameter in prostate cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

Immunohistochemical detection of c-erbB-2 protein in human benign and neoplastic prostate

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

P53 in tumour pathology: can we trust immunocytochemistry?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

Alterations of the P53 gene are associated with the progression of a human prostate carcinoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968568

Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles

11 July 2018

1 reference

12 December 2020

Long-term follow-up after radical prostatectomy. Identification of prognostic variables

1 reference

12 December 2020

Tissue concentrations of prostate-specific antigen in prostatic carcinoma and benign prostatic hyperplasia

1 reference

12 December 2020

Prognostic significance of antigenic heterogeneity, Gleason grade, and ploidy of lymph node metastases in patients with prostate cancer

1 reference

12 December 2020

Quantitative estimation of tissue prostate specific antigen, deoxyribonucleic acid ploidy and cytological grade in fine needle aspiration biopsies for prognosis of hormonally treated prostatic carcinoma

1 reference

12 December 2020

Prognostic significance of changes in prostate-specific markers after endocrine treatment of stage D2 prostatic cancer

1 reference

12 December 2020

Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer

1 reference

12 December 2020

Retinoblastoma and p53 gene expression related to relapse and survival in human breast cancer: an immunohistochemical study

1 reference

12 December 2020

A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies

1 reference

12 December 2020

Grading errors in prostatic needle biopsies: relation to the accuracy of tumor grade in predicting pelvic lymph node metastases

1 reference

12 December 2020

The national survey of prostate cancer in the United States by the American College of Surgeons

1 reference

12 December 2020

Understaging and undergrading of prostate cancer. Argument for postoperative radiation as adjuvant therapy

1 reference

12 December 2020

The dedifferentiation of prostate carcinoma

1 reference

12 December 2020

Pre-Treatment and Post-Treatment Evaluation of Prostatic Adenocarcinoma for Prostatic Specific Acid Phosphatase and Prostatic Specific Antigen by Immunohistochemistry

1 reference

12 December 2020

Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications

1 reference

12 December 2020

Changes in immunohistochemical staining in prostatic adenocarcinoma following diethylstilbestrol therapy

1 reference

12 December 2020

Patterns of progression in prostate cancer

1 reference

12 December 2020

Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup

1 reference

12 December 2020

Carcinoma of the prostate with atypical immunohistological features. Clinical and histologic correlates

1 reference

12 December 2020

Neuroendocrine differentiation in prostatic carcinoma

1 reference

12 December 2020

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 reference

12 December 2020

c-erbB-2 oncoprotein expression in primary human tumors

1 reference

12 December 2020

Analysis of prognostic factors in disseminated prostatic cancer. An update. Dutch Southeastern Urological Cooperative Group

1 reference

12 December 2020

In Situ Hybridization of Prostate-Specific Antigen mRNA in Human Prostate

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1993.344

1 reference

11 August 2017

1 reference

11 August 2017

1 reference